171 related articles for article (PubMed ID: 37079050)
1. The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours.
Hannon Barroeta P; O'Sullivan MJ; Zisterer DM
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8379-8391. PubMed ID: 37079050
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of targeting autophagy for the treatment of malignant rhabdoid tumours.
Hannon Barroeta P; Magnano S; O'Sullivan MJ; Zisterer DM
Cancer Treat Res Commun; 2022; 32():100584. PubMed ID: 35679755
[TBL] [Abstract][Full Text] [Related]
3. Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin.
Coyle R; O'Sullivan MJ; Zisterer DM
Cancer Treat Res Commun; 2022; 32():100579. PubMed ID: 35613525
[TBL] [Abstract][Full Text] [Related]
4. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
Tocmo R; Parkin K
Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
6. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
Habermann KJ; Grünewald L; van Wijk S; Fulda S
Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
9. Adaptive response to GSH depletion and resistance to L-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation.
Lee HR; Cho JM; Shin DH; Yong CS; Choi HG; Wakabayashi N; Kwak MK
Mol Cell Biochem; 2008 Nov; 318(1-2):23-31. PubMed ID: 18587629
[TBL] [Abstract][Full Text] [Related]
10. Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.
Zanotto-Filho A; Masamsetti VP; Loranc E; Tonapi SS; Gorthi A; Bernard X; Gonçalves RM; Moreira JC; Chen Y; Bishop AJ
Mol Cancer Ther; 2016 Dec; 15(12):3000-3014. PubMed ID: 27638861
[TBL] [Abstract][Full Text] [Related]
11. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
Kim EH; Jang H; Roh JL
Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion.
Jin M; Yaung J; Kannan R; He S; Ryan SJ; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4311-9. PubMed ID: 16249513
[TBL] [Abstract][Full Text] [Related]
13. Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression.
Li X; Mu J; Lin Y; Zhao J; Meng X
J Food Biochem; 2021 Jul; 45(7):e13806. PubMed ID: 34080212
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
15. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
16. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
[TBL] [Abstract][Full Text] [Related]
17. Intracellular glutathione content influences the sensitivity of lung cancer cell lines to methylseleninic acid.
Liu C; Liu H; Li Y; Wu Z; Zhu Y; Wang T; Gao AC; Chen J; Zhou Q
Mol Carcinog; 2012 Apr; 51(4):303-14. PubMed ID: 21520298
[TBL] [Abstract][Full Text] [Related]
18. Enhanced thioredoxin, glutathione and Nrf2 antioxidant systems by safflower extract and aceglutamide attenuate cerebral ischaemia/reperfusion injury.
Zhang J; Zhou R; Xiang C; Fan F; Gao J; Zhang Y; Tang S; Xu H; Yang H
J Cell Mol Med; 2020 May; 24(9):4967-4980. PubMed ID: 32266795
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability.
Gallorini M; Petzel C; Bolay C; Hiller KA; Cataldi A; Buchalla W; Krifka S; Schweikl H
Biomaterials; 2015 Jul; 56():114-28. PubMed ID: 25934285
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels.
Zhang HX; Chen Y; Xu R; He QY
Acta Pharmacol Sin; 2018 Oct; 39(10):1661-1669. PubMed ID: 30287928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
